CDH5 and neoplasm: One study, which was published in 2014, has revealed that the Y658 residue of VE-cadherin can be phosphorylated by FAK in in vitro and in vivo models of ECs associated with tumor cells, thus identifying that FAK plays a pivotal role in the dynamics of cell permeabilization in the metastatic tumor endothelium [115].